CD44 and EpCAM: Cancer-Initiating Cell Markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD44 and EpCAM: Cancer-Initiating Cell Markers

Published:2008-12-01 Issue:8 Volume:8 Page:784-804
ISSN:1566-5240
Container-title:Current Molecular Medicine
language:en
Short-container-title:CMM

Author:

Marhaba Rachid,Klingbeil Pamela,Nuebel Tobias,Nazarenko Irina,Buechler Markus,Zoeller Margot

Publisher

Bentham Science Publishers Ltd.

Subject

Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

2. Colorectal Cancer Stem Cells and Targeted Agents;Pharmaceutics;2023-12-12

3. 3D cell subculturing pillar dish for pharmacogenetic analysis and high-throughput screening;Materials Today Bio;2023-12

4. Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer;BMC Cancer;2023-11-10

5. Cancer stem cells: advances in the glucose, lipid and amino acid metabolism;Molecular and Cellular Biochemistry;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP